About this trial
The objectives of this study are to improve HCV linkage-to-care in Chinese women and provide theoretical basis for the scientific formulation of HCV prevention and control strategies for pregnant women.
To understand the epidemiological changes and status of hepatitis C virus (HCV) infection in pregnant women in Shaanxi province in recent 10 years, and to analyze the main influencing factors of hepatitis C infection in pregnant women.
Eligibility criteria
Qualifiers
Pregnant women or parturient women confirmed by blood HCG test.
Patients aged 18 years old and above.
Patients with HCV antibody seropositive or HCV RNA positive from 2014-2023.
Disqualifiers
Patients without valid telephone numbers.
Duplicate records: For duplicate records of the same pregnant woman, only one record should be kept.
Trial design
Treatments tested in this trial
- Standard Direct-acting antivirals (DAA) treatment procedures for patients with hepatitis C